{
  "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
  "Projects": [
    {
      "Id": "Midazolam",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Midazolam-Model/master/Midazolam-Model.json"
    },
    {
      "Id": "Alfentanil",
      "Path": "https://raw.githubusercontent.com/TWendl/Alfentanil-Model/master/Alfentanil.json"
    },
    {
      "Id": "Itraconazole",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Model/master/Itraconazole-Model.json"
    },
    {
      "Id": "Rifampicin",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Model/master/Rifampicin-Model.json"
    },
    {
      "Id": "Fluvoxamine",
      "Path": "https://raw.githubusercontent.com/LMFuhr/Fluvoxamine-Model/master/Fluvoxamine-Model.json"
    },
    {
      "Id": "Itraconazole-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Midazolam-DDI/master/Itraconazole-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Midazolam-DDI/master/Rifampicin-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Alfentanil-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Alfentanil-DDI/master/Rifampicin-Alfentanil-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Alfentanil",
          "Project": "Alfentanil"
        },
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        }
      ]
    },
    {
      "Id": "Fluvoxamine-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Midazolam-DDI/master/Fluvoxamine-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        }
      ]
    },
    {
      "Id": "Itraconazole-Alprazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Alprazolam-DDI/master/Itraconazole-Alprazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Alprazolam",
          "Project": "Alprazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Weibull_Xanax",
          "Project": "Alprazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        }
      ]
    },
    {
      "Id": "Itraconazole-Triazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Triazolam-DDI/master/Itraconazole-Triazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Triazolam",
          "Project": "Triazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Halcion",
          "Project": "Triazolam"
        },
        {
          "Type": "Event",
          "Name": "Standard Meal",
          "Project": "Itraconazole"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        }
      ]
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "DDI Ratios",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Database-for-observed-data/master/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AllPlots": [],
    "GOFMergedPlots": [],
    "ComparisonTimeProfilePlots": [
      {
        "SectionId": 308,
        "Title": "Kashuba 1998",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kashuba 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 517,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Fluvoxamine)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 308,
        "Title": "Lam 2003",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "Lam 2003, 10 mg, SD, midazolam control",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Lam 2003 - Midazolam before Fluvoxamine - Midazolam - PO - 10 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Lam 2003 - Midazolam after Fluvoxamine - Midazolam - PO - 10 mg - Plasma - agg. (n=10)",
            "StartTime": 265,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Fluvoxamine)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 309,
        "Title": "Yasui 1998",
        "SimulationDuration": 48,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Alprazolam-DDI",
            "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1998 - Alprazolam 0.8 mg with itraconazole",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Alprazolam-DDI",
            "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with itraconazole",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1998 - Alprazolam with placebo - Alprazolam - PO - 0.8 mg - Plasma - agg. (n=10)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Ahonen 1995",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Backman 1998",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase II (during Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase II (with Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase III (4 days after Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 170,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment Phase III (with Itraconazole)",
            "Symbol": "Triangle"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1994",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 1 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 2,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 4 iv)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) with Perpetrator (Itraconazole) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 6 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 122,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Prueksaritanont 2017",
        "SimulationDuration": 72,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail alone - Midazolam - PO - 10 µg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail + Itraconazole - Midazolam - PO - 10 µg - Plasma - agg. (n=8)",
            "StartTime": 72,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Templeton 2010",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Templeton 2010",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 50 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 100 mg Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 200 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 200 mg Itraconazole)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 400 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 400 mg Itraconazole)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 311,
        "Title": "Neuvonen 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Control phase (Triazolam without Itraconazole) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ simultaneously) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (Itraconazole administered simultaneously)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 3 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 3,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (Itraconazole administered 3h before)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 12 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 12,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (Itraconazole administered 12h before)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 24 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (Itraconazole administered 24h before)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 311,
        "Title": "Varhe 1994",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Varhe 1994 - Triazolam 0.25 mg control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Varhe 1994 - Triazolam with placebo - Triazolam - PO - 0.25 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Varhe 1994 - Triazolam with Itraconazole - Triazolam - PO - 0.25 mg - Plasma - agg. (n=9)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 1997",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 1997 20 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Alfentanil - IV - 20 µg/kg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - with Perpetrator (Rifampicin) - Alfentanil - IV - 20 µg/kg - Plasma - agg. (n=9)",
            "StartTime": 120.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2004 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 105,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2004 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 60 µg/kg PO - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 (60 µg/kg) Control (Perpetrator Placebo) - Alfentanil - PO - 60 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 (60 µg/kg) with Perpetrator (Rifampicin) - Alfentanil - PO - 60 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 129,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (iv during sequential administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b IV 1mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Control sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Rifampin coadmin sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (iv during simultaneous administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b IV 1mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Control simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Rifampin coadmin simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (po during sequential administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b PO 4mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Control sequential - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Rifampin coadmin sequential - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 111,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (po during simultaneous administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b PO 4mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Control simultaneous - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 21,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Rifampin coadmin simultaneous - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Phimmasone 2001",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Phimmasone 2001 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=6)",
            "StartTime": 107,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Backman 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Backman 1998 (Phase IV and V vs. I)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase IV (with Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 185,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment Phase V (with Rifampicin)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Chung 2006",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 166,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Eap 2004 (0.075 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 0.075 mg Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=21)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 0.075 mg with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg - Plasma - agg. (n=4)",
            "StartTime": 90,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Eap 2004 (7.5 mg)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
            "StartTime": 114,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gorski 2003 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gorski 2003 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gurley 2006",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gurley 2008a",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 1997",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2004 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 104,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2004 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 128,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2011 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2011 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kim 2018",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kim 2018 (male)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Link 2008 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Link 2008 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Phimmasone 2001",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 106,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Prueksaritanont 2017",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail alone - Midazolam - PO - 10 µg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail + Rifampin - Midazolam - PO - 10 µg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Reitman 2011",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 648,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Week 0 after treatment with rifampicin",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 816,
            "TimeUnit": "h",
            "Color": "#d6604d",
            "Caption": "Week 1 after treatment with rifampicin",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 984,
            "TimeUnit": "h",
            "Color": "#f4a582",
            "Caption": "Week 2 after treatment with rifampicin",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 1320,
            "TimeUnit": "h",
            "Color": "#fddbc7",
            "Caption": "Week 4 after treatment with rifampicin",
            "Symbol": "Circle"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Shin 2013",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Shin 2013",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2013 - Control phase (Midazolam alone) - Midazolam - IV - 1 mg - Plasma - agg. (n=24)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2013 - CYP3A4 induced phase (Midazolam + rifampicin) - Midazolam - IV - 2.5 mg - Plasma - agg. (n=24)",
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Shin 2016",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Shin 2016",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2016 - Midazolam alone - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2016 - Midazolam + rifampicin - Midazolam - IV - 2.5 mg - Plasma - agg. (n=12)",
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Szalat 2007",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "van Dyk 2018",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "van Dyk 2018 - Midazolam in Caucasian at baseline - Midazolam - PO - 1 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 156,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      }
    ],
    "DDIRatioPlots": [
      {
        "SectionId": 2,
        "Title": "CYP3A4 DDI",
        "PKParameter": "AUC|CMAX",
        "PlotType": "predictedVsObserved|residualsVsObserved",
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure",
          "Table"
        ],
        "Groups": [
          {
            "Caption": "Itra+Mida (Mida iv)",
            "Color": "#808080",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 378,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 74,
                  "EndTime": 122,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itra+Mida (Mida po)",
            "Color": "#808080",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 50,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Ahonen 1995",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
                  "StartTime": 74,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 58,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 74,
                  "EndTime": 170,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 59,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 170,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 370,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1994",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 377,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 2,
                  "EndTime": 74,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 379,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 122,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1097,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
                  "StartTime": 72,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 424,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 425,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 426,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifa+Mida (Mida iv)",
            "Color": "#008080",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 179,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 276,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 1997",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
                  "StartTime": 120,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 280,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 104,
                  "EndTime": 128,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 294,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 295,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 296,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 297,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2036,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kim 2018 (male)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 342,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 389,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
                  "StartTime": 106,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1092,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Shin 2013",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
                  "StartTime": 216,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1095,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Shin 2016",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
                  "StartTime": 216,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 422,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Szalat 2007",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifa+Mida (Mida po)",
            "Color": "#008080",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 54,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1996",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
                  "StartTime": 113,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 56,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 113,
                  "EndTime": 185,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 57,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 185,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 113,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Chung 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
                  "StartTime": 166,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 129,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
                  "StartTime": 90,
                  "EndTime": 114,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 132,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
                  "StartTime": 114,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 177,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 215,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 221,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2008",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 286,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 128,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 304,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 305,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 306,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 307,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 344,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1098,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 392,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 648,
                  "EndTime": 816,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 393,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 816,
                  "EndTime": 984,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 394,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 984,
                  "EndTime": 1320,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2002,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - van Dyk 2018",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
                  "StartTime": 162,
                  "EndTime": 168,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin+Alfentanil (Alfentanil iv)",
            "Color": "#C00000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 278,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 1997 20 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 1997 20 µg/kg IV and Rifampicin",
                  "StartTime": 120.5,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 283,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 15 µg/kg IV and Rifampicin",
                  "StartTime": 105,
                  "EndTime": 129,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 299,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 300,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 301,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 50 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 302,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 763,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b IV 1mg - control",
                  "StartTime": 0,
                  "EndTime": 24,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 767,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b IV 1mg - control",
                  "StartTime": 24,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 391,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Phimmasone 2001 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin",
                  "StartTime": 107,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin+Alfentanil (Alfentanil po)",
            "Color": "#C00000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 288,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 60 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 60 µg/kg PO and Rifampicin",
                  "StartTime": 129,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 309,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 310,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 311,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 312,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 771,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b PO 4mg - control",
                  "StartTime": 0,
                  "EndTime": 21,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
                  "StartTime": 111,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 775,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b PO 4mg - control",
                  "StartTime": 21,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Fluvoxamine+Midazolam (Midazolam iv)",
            "Color": "#C04000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2007,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kashuba 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
                  "StartTime": 517,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Fluvoxamine+Midazolam (Midazolam po)",
            "Color": "#C04000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1089,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "Lam 2003, 10 mg, SD, midazolam control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
                  "StartTime": 265,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole+Alprazolam (Alprazolam po)",
            "Color": "#00FF00",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1026,
                "SimulationControl": {
                  "Project": "Itraconazole-Alprazolam-DDI",
                  "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with placebo",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Alprazolam-DDI",
                  "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with itraconazole",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole+Triazolam (Triazolam po)",
            "Color": "#C0C000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1078,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1079,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
                  "StartTime": 3,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1080,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
                  "StartTime": 12,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1081,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
                  "StartTime": 24,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1029,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Varhe 1994 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ]
  },
  "Inputs": [],
  "Sections": [
    {
      "Id": 1,
      "Title": "1 Introduction",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md",
      "Sections": [
        {
          "Id": 11,
          "Title": "1.1 Objective",
          "Content": "Content/Qualification_DDI_CYP3A4_objective.md"
        },
        {
          "Id": 12,
          "Title": "1.2 CYP3A4 DDI Network",
          "Content": "Content/Qualification_DDI_CYP3A4_network_description.md",
          "Sections": [
            {
              "Id": 1201,
              "Title": "Clarithromycin - Midazolam DDI",
              "Content": "Content/Clarithromycin-Midazolam-DDI.md"
            },
            {
              "Id": 1202,
              "Title": "Clarithromycin - Triazolam DDI",
              "Content": "Content/Clarithromycin-Triazolam-DDI.md"
            },
            {
              "Id": 1203,
              "Title": "Erythromycin - Alfentanil DDI",
              "Content": "Content/Erythromycin-Alfentanil-DDI.md"
            },
            {
              "Id": 1204,
              "Title": "Erythromycin - Alprazolam DDI",
              "Content": "Content/Erythromycin-Alprazolam-DDI.md"
            },
            {
              "Id": 1205,
              "Title": "Erythromycin - Midazolam DDI",
              "Content": "Content/Erythromycin-Midazolam-DDI.md"
            },
            {
              "Id": 1206,
              "Title": "Erythromycin - Triazolam DDI",
              "Content": "Content/Erythromycin-Triazolam-DDI.md"
            },
            {
              "Id": 1207,
              "Title": "Fluvoxamine - Alprazolam DDI",
              "Content": "Content/Fluvoxamine-Alprazolam-DDI.md"
            },
            {
              "Id": 1208,
              "Title": "Fluvoxamine - Midazolam DDI",
              "Content": "Content/Fluvoxamine-Midazolam-DDI.md"
            },
            {
              "Id": 1209,
              "Title": "Itraconazole - Alprazolam DDI",
              "Content": "Content/Itraconazole-Alprazolam-DDI.md"
            },
            {
              "Id": 1210,
              "Title": "Itraconazole - Midazolam DDI",
              "Content": "Content/Itraconazole-Midazolam-DDI.md"
            },
            {
              "Id": 1211,
              "Title": "Itraconazole-Triazolam-DDI",
              "Content": "Content/Itraconazole - Triazolam DDI.md"
            },
            {
              "Id": 1212,
              "Title": "Verapamil - Midazolam DDI",
              "Content": "Content/Verapamil-Midazolam-DDI.md"
            },
            {
              "Id": 1213,
              "Title": "Efavirenz-Alfentanil-DDI",
              "Content": "Content/Efavirenz - Alfentanil DDI.md"
            },
            {
              "Id": 1214,
              "Title": "Efavirenz - Midazolam DDI",
              "Content": "Content/Efavirenz-Midazolam-DDI.md"
            },
            {
              "Id": 1215,
              "Title": "Rifampicin - Alfentanil DDI",
              "Content": "Content/Rifampicin-Alfentanil-DDI.md"
            },
            {
              "Id": 1216,
              "Title": "Rifampicin - Alprazolam DDI",
              "Content": "Content/Rifampicin-Alprazolam-DDI.md"
            },
            {
              "Id": 1217,
              "Title": "Rifampicin - Midazolam DDI",
              "Content": "Content/Rifampicin-Midazolam-DDI.md"
            },
            {
              "Id": 1218,
              "Title": "Rifampicin - Triazolam DDI",
              "Content": "Content/Rifampicin-Triazolam-DDI.md"
            }
          ]
        }
      ]
    },
    {
      "Id": 2,
      "Title": "2 Qualification of Use Case CYP3A4-mediated DDI",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
    },
    {
      "Id": 3,
      "Title": "3 Concentration-Time Profiles",
      "Content": "Content/Intro_evaluation_DDI_network.md",
      "Sections": [
        {
          "Id": 301,
          "Title": "3.1 Clarithromycin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 302,
          "Title": "3.2 Clarithromycin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 303,
          "Title": "3.3 Erythromycin - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 304,
          "Title": "3.4 Erythromycin - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 305,
          "Title": "3.5 Erythromycin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 306,
          "Title": "3.6 Erythromycin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 307,
          "Title": "3.7 Fluvoxamine - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 308,
          "Title": "3.8 Fluvoxamine - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 309,
          "Title": "3.9 Itraconazole - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 310,
          "Title": "3.10 Itraconazole - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 311,
          "Title": "3.11 Itraconazole - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 312,
          "Title": "3.12 Verapamil - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 313,
          "Title": "3.13 Efavirenz - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 314,
          "Title": "3.14 Efavirenz - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 315,
          "Title": "3.15 Rifampicin - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 316,
          "Title": "3.16 Rifampicin - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 317,
          "Title": "3.17 Rifampicin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        },
        {
          "Id": 318,
          "Title": "3.18 Rifampicin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md"
        }
      ]
    },
    {
      "Id": 4,
      "Title": "4 References",
      "Content": "Content/References.md",
      "Sections": []
    },
    {
      "Id": 5,
      "Title": "5 Appendix",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Empty.md",
      "Sections": [
        {
          "Id": 51,
          "Title": "5.1 Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/OSPS_Introduction.md"
        },
        {
          "Id": 52,
          "Title": "5.2 Mathematical Implementation of Drug-Drug Interactions",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Mathematical_Implementation_of_DDI.md"
        },
        {
          "Id": 53,
          "Title": "5.3 Automatic (re)-qualification workflow",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/master/Qualification_Workflow.md"
        }
      ]
    }
  ],
  "Intro": [
    {
      "Path": "Content/titlepage.md"
    }
  ]
}